Using an air quality monitor to encourage smoke-free homes for cancer patients
Freedom to Breathe: Pilot Study Towards Achieving Environmental Justice for Cancer Patients and Their Families
This study is testing if using an air quality monitor can help cancer patients who smoke create smoke-free homes and quit smoking.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 10 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Memorial Sloan Kettering Cancer Center Academic / other |
| Locations | 8 sites (Basking Ridge, New Jersey and 7 other locations) |
| Trial ID | NCT06693700 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of an indoor air quality monitor in promoting a smoke-free environment for cancer patients enrolled in the Tobacco Treatment Program at Memorial Sloan Kettering Cancer Center. Participants will use the AirGradient ONE monitor to track indoor air quality and receive feedback aimed at reducing tobacco use in their homes. The study focuses on adult patients who currently smoke and have completed initial counseling sessions. The goal is to assess whether monitoring air quality can lead to improved smoking cessation outcomes.
Who should consider this trial
Good fit: Ideal candidates are adult cancer patients who smoke and are enrolled in the Tobacco Treatment Program.
Not a fit: Patients who do not allow smoking in their homes or have already quit smoking may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could help cancer patients reduce or quit smoking, leading to better health outcomes.
How similar studies have performed: Other studies have shown that interventions aimed at improving indoor air quality can support smoking cessation efforts, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult (aged \>18 years) MSK patients as per the EHR * Has been referred and enrolled in the MSK TTP and completed the initial counseling session as per the TTP clinical database * Reports current (within the past 30 days) tobacco use (i.e., cigarettes and/or any other tobacco products) as per the TTP Intake form * Must be English-speaking in the EHR * Must be reachable by phone as per self-report * Must have Wi-Fi available at home as per self-report Exclusion Criteria: * Patient reports that no smoking is allowed, by them or anyone else, in the home as per the TTP intake form and/or per self-report
Where this trial is running
Basking Ridge, New Jersey and 7 other locations
- Memorial Sloan Kettering Basking Ridge (Consent only) — Basking Ridge, New Jersey, United States (Recruiting)
- Memorial Sloan Kettering Monmouth (Consent only) — Middletown, New Jersey, United States (Recruiting)
- Memorial Sloan Kettering Bergen (Consent only) — Montvale, New Jersey, United States (Recruiting)
- Memorial Sloan Kettering Suffolk-Commack (Consent only) — Commack, New York, United States (Recruiting)
- Memorial Sloan Kettering Westchester (Consent only) — Harrison, New York, United States (Recruiting)
- City College of New York (Data Collection AND Data Analysis) — New York, New York, United States (Not_yet_recruiting)
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) — New York, New York, United States (Recruiting)
- Memorial Sloan Kettering Nassau (Consent only) — Uniondale, New York, United States (Recruiting)
Study contacts
- Principal investigator: Gleneara Bates-Pappas, PhD, LMSW — Memorial Sloan Kettering Cancer Center
- Study coordinator: Gleneara Bates-Pappas, PhD, LMSW
- Email: batespag@mskcc.org
- Phone: 212-610-0507
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.